TECX - Tectonic Therapeutic Inc.
IEX Last Trade
19.19
0.190 0.990%
Share volume: 14,001
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$19.00
0.19
1.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
5.49%
1 Month
6.67%
3 Months
-90.74%
6 Months
-89.90%
1 Year
-91.29%
2 Year
-85.70%
Key data
Stock price
$19.19
DAY RANGE
N/A - N/A
52 WEEK RANGE
$15.00 - $237.60
52 WEEK CHANGE
-$0.91
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: avrobio.com
Employees: 95
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: avrobio.com
Employees: 95
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
Recent news